69 related articles for article (PubMed ID: 23703752)
1. Mesoporous calcium carbonate as a phase stabilizer of amorphous celecoxib--an approach to increase the bioavailability of poorly soluble pharmaceutical substances.
Forsgren J; Andersson M; Nilsson P; Mihranyan A
Adv Healthc Mater; 2013 Nov; 2(11):1469-76. PubMed ID: 23703752
[TBL] [Abstract][Full Text] [Related]
2. Microscopic Cracks Modulate Nucleation and Solid-State Crystallization Tendency of Amorphous Celecoxib.
Thakore SD; Das K; Dalvi SV; Reddy CM; Bansal AK
Mol Pharm; 2024 Jan; 21(1):76-86. PubMed ID: 38051598
[TBL] [Abstract][Full Text] [Related]
3. Mesoporous Matrices as a Promising New Generation of Carriers for Multipolymorphic Active Pharmaceutical Ingredient Aripiprazole.
Minecka A; Tarnacka M; Jurkiewicz K; Żakowiecki D; Kamiński K; Kamińska E
Mol Pharm; 2023 Nov; 20(11):5655-5667. PubMed ID: 37756382
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the liquisolid technique and co-milling for loading of a poorly soluble drug in inorganic porous excipients.
Ogadah CU; Mrštná K; Matysová L; Müllertz A; Rades T; Niederquell A; Šklubalová Z; Vraníková B
Int J Pharm; 2024 Jan; 650():123702. PubMed ID: 38086492
[TBL] [Abstract][Full Text] [Related]
5. In-Vitro and In-Vivo Evaluation of Velpatasvir- Loaded Mesoporous Silica Scaffolds. A Prospective Carrier for Drug Bioavailability Enhancement.
Mehmood Y; Khan IU; Shahzad Y; Khan RU; Iqbal MS; Khan HA; Khalid I; Yousaf AM; Khalid SH; Asghar S; Asif M; Hussain T; Shah SU
Pharmaceutics; 2020 Mar; 12(4):. PubMed ID: 32231052
[TBL] [Abstract][Full Text] [Related]
6. Amorphization of Low Soluble Drug with Amino Acids to Improve Its Therapeutic Efficacy: a State-of-Art-Review.
Kapoor DU; Singh S; Sharma P; Prajapati BG
AAPS PharmSciTech; 2023 Dec; 24(8):253. PubMed ID: 38062314
[TBL] [Abstract][Full Text] [Related]
7. Stability of Rapidly Crystallizing Sulfonamides Glasses by Fast Scanning Calorimetry: Crystallization Kinetics and Glass-Forming Ability.
Lapuk SE; Mukhametzyanov TA; Schick C; Gerasimov AV
J Pharm Sci; 2024 May; 113(5):1257-1264. PubMed ID: 38070775
[TBL] [Abstract][Full Text] [Related]
8. Tuning the Physical State of Aripiprazole by Mesoporous Silica.
Kramarczyk D; Knapik-Kowalczuk J; Klimontko J; Kurek M; Jachowicz R; Paluch M
Mol Pharm; 2024 May; 21(5):2315-2326. PubMed ID: 38644570
[TBL] [Abstract][Full Text] [Related]
9. Unlocking the mysterious polytypic features within vaterite CaCO
San X; Hu J; Chen M; Niu H; Smeets PJM; Malliakas CD; Deng J; Koo K; Dos Reis R; Dravid VP; Hu X
Nat Commun; 2023 Nov; 14(1):7858. PubMed ID: 38030637
[TBL] [Abstract][Full Text] [Related]
10. Size and phase preservation of amorphous calcium carbonate nanoparticles in aqueous media using different types of lignin for contrast-enhanced ultrasound imaging.
Chuzeville L; Aissani A; Manisekaran A; Fleming Y; Grysan P; Contal S; Chary A; Duday D; Couture O; Anand R; Thomann JS
J Colloid Interface Sci; 2024 Mar; 658():584-596. PubMed ID: 38134667
[TBL] [Abstract][Full Text] [Related]
11. Microfluidic Vaterite Synthesis: Approaching the Nanoscale Particles.
Reznik I; Baranov MA; Cherevkov SA; Konarev PV; Volkov VV; Moshkalev S; Trushina DB
Nanomaterials (Basel); 2023 Dec; 13(23):. PubMed ID: 38063771
[TBL] [Abstract][Full Text] [Related]
12. Crystallisation Behaviour of Pharmaceutical Compounds Confined within Mesoporous Silicon.
Jones ECL; Bimbo LM
Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32121652
[TBL] [Abstract][Full Text] [Related]
13. Impact of drug loading in mesoporous silica-amorphous formulations on the physical stability of drugs with high recrystallization tendency.
Antonino RSCMQ; Ruggiero M; Song Z; Nascimento TL; Lima EM; Bohr A; Knopp MM; Löbmann K
Int J Pharm X; 2019 Dec; 1():100026. PubMed ID: 31517291
[TBL] [Abstract][Full Text] [Related]
14. Importance of Mesoporous Silica Particle Size in the Stabilization of Amorphous Pharmaceuticals-The Case of Simvastatin.
Knapik-Kowalczuk J; Kramarczyk D; Chmiel K; Romanova J; Kawakami K; Paluch M
Pharmaceutics; 2020 Apr; 12(4):. PubMed ID: 32331310
[TBL] [Abstract][Full Text] [Related]
15. Characterization and Exploration of Placket-Burman-Designed Porous Calcium Carbonate (Vaterite) Microparticles.
Singh A; Das SS; Verma PRP; Ruokolainen J; Kesari KK; Singh SK
ACS Omega; 2023 Nov; 8(47):44611-44623. PubMed ID: 38046299
[TBL] [Abstract][Full Text] [Related]
16. New Perspectives for Antihypertensive Sartans as Components of Co-crystals and Co-amorphous Solids with Improved Properties and Multipurpose Activity.
Turek M; Różycka-Sokołowska E; Owsianik K; Bałczewski P
Mol Pharm; 2024 Jan; 21(1):18-37. PubMed ID: 38108281
[TBL] [Abstract][Full Text] [Related]
17. Current Techniques of Water Solubility Improvement for Antioxidant Compounds and Their Correlation with Its Activity: Molecular Pharmaceutics.
Budiman A; Rusdin A; Aulifa DL
Antioxidants (Basel); 2023 Feb; 12(2):. PubMed ID: 36829937
[TBL] [Abstract][Full Text] [Related]
18. Monodisperse and Nanometric-Sized Calcium Carbonate Particles Synthesis Optimization.
Persano F; Nobile C; Piccirillo C; Gigli G; Leporatti S
Nanomaterials (Basel); 2022 Apr; 12(9):. PubMed ID: 35564205
[TBL] [Abstract][Full Text] [Related]
19. Modification of the Physicochemical Properties of Active Pharmaceutical Ingredients via Lyophilization.
Taldaev A; Pankov DI; Terekhov RP; Zhevlakova AK; Selivanova IA
Pharmaceutics; 2023 Nov; 15(11):. PubMed ID: 38004585
[TBL] [Abstract][Full Text] [Related]
20. Mesoporous Silica as an Alternative Vehicle to Overcome Solubility Limitations.
Becker T; Heitkötter J; Krome AK; Schiefer A; Pfarr K; Ehrens A; Grosse M; Sandargo B; Stammberger I; Stadler M; Hübner MP; Kehraus S; Hoerauf A; Wagner KG
Pharmaceutics; 2024 Mar; 16(3):. PubMed ID: 38543280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
